At NOVAPATH DIAGNOSTICS, Immunohistochemistry (IHC) forms the cornerstone of accurate and advanced cancer diagnosis. IHC combines anatomical, immunological, and biochemical techniques to detect specific antigens (proteins) in tissues using targeted antibodies - helping pathologists identify the type, origin, and biological behavior of tumors with precision.
It is an essential tool for oncopathology, providing information beyond morphology and guiding treatment decisions and prognostication. Our state-of-the-art IHC laboratory is equipped with cutting-edge technology and staffed by experienced pathologists and technologists dedicated to delivering accurate and timely results.
We offer an extensive range of diagnostic and prognostic IHC markers across multiple tumor systems, processed on state-of-the-art automated platforms for accuracy, consistency, and reproducibility.
Ensuring standardization and reproducibility across all tests
For even low-expression biomarkers with exceptional clarity
Expert review and validation for every case
Internal and external quality assessment for every batch
Proper collection, labeling and transportation of tissue samples
Fixation, embedding, and microtomy for optimal section quality
Precision antibody application using automated platforms
Expert pathologist interpretation and comprehensive reporting
Precise identification of tumor type and origin, especially in metastatic cancers and cancers of unknown primary.
Evaluation of tumor proliferation indices and other markers that predict disease behavior and patient outcomes.
Identification of therapeutic targets like hormone receptors, HER2, PD-L1 for personalized treatment selection.
Distinguishing between morphologically similar tumors that require different treatment approaches.
At NOVAPATH DIAGNOSTICS, we believe that every IHC result tells a story - of cellular origin, molecular pathways, and therapeutic potential. Our comprehensive immunohistochemistry services are designed to provide clinicians with the critical information needed for optimal patient management and personalized treatment strategies.
We are committed to providing clinically relevant, high-precision IHC reports that empower oncologists, surgeons, and other healthcare providers to make informed, confident, and personalized treatment decisions. Our team of expert pathologists, specialized technologists, and support staff work collaboratively to ensure that each report provides the comprehensive information needed for optimal patient care, supported by cutting-edge technology, rigorous quality assurance protocols, and continuous professional development.
Trust NOVAPATH DIAGNOSTICS for all your immunohistochemistry needs - where precision meets compassion in diagnostic pathology.
+91- 9220405078
novapathdiagnostics1@gmail.com
